Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-05T15:22:11.440Z Has data issue: false hasContentIssue false
  • English
  • Français

Delivering adaptive radiotherapy to the bladder during radical treatment

Published online by Cambridge University Press:  01 August 2012

Claire Arthur ,
Jac Livsey  and
Ananya Choudhury
Claire Arthur*
Affiliation:
The Christie NHS Foundation Trust, Manchester, United Kingdom
Jac Livsey
Affiliation:
The Christie NHS Foundation Trust, Manchester, United Kingdom
Ananya Choudhury
Affiliation:
The Christie NHS Foundation Trust, Manchester, United Kingdom The University of Manchester, United Kingdom
*
Correspondence to: Claire Arthur, The Christie NHS Foundation Trust, Manchester, United Kingdom. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Radical radiotherapy to the bladder for muscle-invasive bladder cancer is a challenging treatment to plan and deliver because of organ mobility and its varying volume. The dynamic target volume can be tracked with imaging during the treatment course, enabling an adaptive response and adjustment of the patient’s individual treatment plan. This article summarises the difficulties encountered when treating the bladder, different approaches to patient imaging and adaptive radiotherapy techniques. Ultimately these technological advances support the delivery of a personalised treatment plan to ensure optimal dose delivery to the tumour and simultaneous sparing of adjacent normal tissue.

Keywords

BladderAdaptiveImagingRadiotherapy
Type
Literature Review
Information
Journal of Radiotherapy in Practice , Volume 12 , Issue 2 , June 2013 , pp. 195 - 202
Copyright
Copyright © Cambridge University Press 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kotwal, S, Choudhury, A, Johnston, C, Paul, AB, Whelan, P, Kiltie, AE. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center. Int J Radiat Oncol Biol Phys 2008; 70:456–463.Google Scholar
Cowan, RA, McBain, CA, Ryder, WD, Wylie, JP, Logue, JP, Turner, SL, Van der Voet, J, Collins, CD, Khoo, VS, Read, GR. Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy. Int J Radiat Oncol Biol Phys 2004; 59:197–207.CrossRefGoogle ScholarPubMed
International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party. International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial. J Clin Oncol 2011; 29:2171–2177.Google Scholar
Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data. Eur Urol 2005; 48:202–206.Google Scholar
Hoskin, PJ, Rojas, AM, Bentzen, SM, Saunders, MI. Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma. J Clin Oncol 2010; 28:4912–4918.CrossRefGoogle ScholarPubMed
James, ND, Hussain, SA, Hall, E et al. Results of a phase III randomised trial of synchronous chemoradiotherapy (CRT) compared to radiotherapy (RT) alone in muscle-invasive bladder cancer (MIBC) (BC2001 CRUK/01/004). J Clin Oncol 2010; 28:15s (suppl; abstr 4517).Google Scholar
Pos, F, Remeijer, P. Adaptive management of bladder cancer radiotherapy. Semin Radiat Oncol 2010; 20:116–120.Google Scholar
Sterzing, F, Engenhart-Cabillic, R, Flentje, M, Debus, J. Image-guided radiotherapy: a new dimension in radiation oncology. Dtsch Arztebl Int 2011; 108:274–280.Google ScholarPubMed
Logue, J, McBain, CA. Radiation therapy for muscle-invasive bladder cancer: treatment planning and delivery. Clin Oncol (R Coll Radiol) 2005; 17:508–513.Google Scholar
Button, MR, Staffurth, JN. Clinical application of image-guided radiotherapy in bladder and prostate cancer. Clin Oncol (R Coll Radiol) 2010; 22:698–706.Google Scholar
Burridge, N, Amer, A, Marchant, T, Sykes, J, Stratford, J, Henry, A, McBain, C, Price, P, Moore, C. Online adaptive radiotherapy of the bladder: small bowel irradiated- volume reduction. Int J Radiat Oncol Biol Phys 2006; 66:892–897.CrossRefGoogle ScholarPubMed
Coen, JJ, Zietman, AL, Kaufman, DS, Shipley, WU. Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer. Urol Oncol 2007; 25:76–84.Google Scholar
Muren, LP, Redpath, AT, Lord, H, McLaren, D. Image-guided radiotherapy of bladder cancer: bladder volume variation and its relation to margins. Radiother Oncol 2007; 84:307–313.CrossRefGoogle ScholarPubMed
Murthy, V, Master, Z, Adurkar, P, Mallick, I, Mahantshetty, U, Bakshi, G, Tongaonkar, H, Shrivastava, S. ‘Plan of the day’ adaptive radiotherapy for bladder cancer using helical tomotherapy. Radiother Oncol 2011; 99:55–60.Google Scholar
Viswanathan, AN, Yorke, ED, Marks, LB, Eifel, PJ, Shipley, WU. Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 2010; 76:S116–S122.Google Scholar
McBain, CA, Khoo, VS, Buckley, DL, Sykes, JS, Green, MM, Cowan, RA, Hutchinson, CE, Moore, CJ, Price, PM. Assessment of bladder motion for clinical radiotherapy practice using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009; 75:664–671.CrossRefGoogle ScholarPubMed
Turner, SL, Swindell, R, Bowl, N, Marrs, J, Brookes, B, Read, G, Cowan, RA. Bladder movement during radiation therapy for bladder cancer: implications for treatment planning. Int J Radiat Oncol Biol Phys 1997; 39:355–360.Google Scholar
McBain, CA, Henry, AM, Sykes, J, Amer, A, Marchant, T, Moore, CM, Davies, J, Stratford, J, McCarthy, C, Porritt, B, Williams, P, Khoo, VS, Price, P. X-ray volumetric imaging in image-guided radiotherapy: the new standard in on-treatment imaging. Int J Radiat Oncol Biol Phys 2006; 64:625–634.CrossRefGoogle ScholarPubMed
Ost, P, De Gersem, W, De Potter, B, Fonteyne, V, De Neve, W, De Meerleer, G. A comparison of the acute toxicity profile between two-dimensional and three-dimensional image-guided radiotherapy for postoperative prostate cancer. Clin Oncol (R Coll Radiol) 2011; 23:344–349.CrossRefGoogle ScholarPubMed
Faroudi, F, Wong, J, Kron, T et al. Online adaptive radiotherapy for muscle-invasive bladder cancer: results of a pilot study. Int. J. Radiation Oncol Biol. Phys 2010; doi:10.1016/j.ijrobp.2010.06.061.Google Scholar
Varadhan, R, Hui, SK, Way, S et al. Assessing prostate, bladder and rectal doses during image guided radiation therapy – need for plan adaptation? Journal of Applied Clinical Medical Physics 2009; 10:56–74.CrossRefGoogle ScholarPubMed
Foroudi, F, Wong, J, Haworth, A, Baille, A, McAlpine, J, Rolfo, A, Kron, T, Roxby, P, Paneghel, A, Williams, S, Duchesne, G, Tai, KH. Offline adaptive radiotherapy for bladder cancer using cone beam computed tomography. J Med Imaging Radiat Oncol 2009; 53:226–233.Google Scholar
Lagendijk, JJ, Raaymakers, BW, Raaijmakers, AJ, Overweg, J, Brown, KJ, Kerkhof, EM, Van der Put, RW, Hårdemark, B, van Vulpen, M, Van der Heide, UA. MRI/linac integration. Radiother Oncol 2008; 86:25–29.Google Scholar
Hulshof, MC, van Andel, G, Bel, A, Gangel, P, van De Kamer, JB. Intravesical markers for delineation of target volume during external focal irradiation of bladder carcinomas. Radiother Oncol 2007; 84:49–51.Google Scholar
Mangar, S, Thompson, A, Miles, E, Huddart, R, Horwich, A, Khoo, V. A feasibility study of using gold seeds as fiducial markers for bladder localization during radical radiotherapy. Br J Radiol 2007; 80:279–283.Google Scholar
Pos, F, Bex, A, Dees-Ribbers, HM, Betgen, A, van Herk, M, Remeijer, P. Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer. Radiother Oncol 2009; 93:364–367.Google Scholar
Parliament, MB, Murray, D. Single nucleotide polymorphisms of DNA repair genes as predictors of radioresponse. Semin Radiat Oncol 2010; 20:232–240.CrossRefGoogle ScholarPubMed
West, CM, McKay, MJ, Hölscher, T, Baumann, M, Stratford, IJ, Bristow, RG, Iwakawa, M, Imai, T, Zingde, SM, Anscher, MS, Bourhis, J, Begg, AC, Haustermans, K, Bentzen, SM, Hendry, JH. Molecular markers predicting radiotherapy response: report and recommendations from an International Atomic Energy Agency technical meeting. Int J Radiat Oncol Biol Phys 2005; 62:1264–1273.CrossRefGoogle ScholarPubMed
Choudhury, A, Nelson, LD, Teo, MT, Chilka, S, Bhattarai, S, Johnston, CF, Elliott, F, Lowery, J, Taylor, CF, Churchman, M, Bentley, J, Knowles, MA, Harnden, P, Bristow, RG, Bishop, DT, Kiltie, AE. MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer. Cancer Res 2010; 70:7017–7026.CrossRefGoogle ScholarPubMed